Market Cap ₹30 Cr.
Stock P/E
P/B 2.5
Current Price ₹60
Book Value ₹ 24.2
Face Value 10
52W High ₹77.9
Dividend Yield 0%
52W Low ₹ 37
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) |
|---|
| Net Sales |
| Other Income |
| Total Income |
| Total Expenditure |
| Operating Profit |
| Interest |
| Depreciation |
| Exceptional Income / Expenses |
| Profit Before Tax |
| Provision for Tax |
| Profit After Tax |
| Adjustments |
| Profit After Adjustments |
| Adjusted Earnings Per Share |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
|---|---|---|---|---|---|
| Net Sales | 8 | 8 | 18 | 28 | |
| Other Income | 0 | 0 | 0 | 0 | |
| Total Income | 8 | 8 | 18 | 28 | |
| Total Expenditure | 8 | 8 | 16 | 26 | |
| Operating Profit | 0 | 0 | 2 | 3 | |
| Interest | 0 | 0 | 0 | 0 | |
| Depreciation | 0 | 0 | 0 | 0 | |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | |
| Profit Before Tax | 0 | 0 | 2 | 2 | |
| Provision for Tax | 0 | 0 | 0 | 1 | |
| Profit After Tax | 0 | 0 | 1 | 2 | |
| Adjustments | 0 | 0 | 0 | 0 | |
| Profit After Adjustments | 0 | 0 | 1 | 2 | |
| Adjusted Earnings Per Share | 0.4 | 0.3 | 4.5 | 3.4 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 56% | 52% | 0% | 0% |
| Operating Profit CAGR | 50% | 0% | 0% | 0% |
| PAT CAGR | 100% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 28% | NA% | NA% | NA% |
| ROE Average | 24% | 37% | 30% | 30% |
| ROCE Average | 32% | 34% | 29% | 29% |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|
| Shareholder's Funds | 1 | 1 | 2 | 12 |
| Minority's Interest | 0 | 0 | 0 | 0 |
| Borrowings | 0 | 0 | 1 | 0 |
| Other Non-Current Liabilities | -0 | -0 | 0 | -0 |
| Total Current Liabilities | 3 | 2 | 2 | 2 |
| Total Liabilities | 3 | 3 | 5 | 14 |
| Fixed Assets | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 2 | 2 |
| Total Current Assets | 3 | 3 | 3 | 12 |
| Total Assets | 3 | 3 | 5 | 14 |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 0 | 1 | 0 |
| Cash Flow from Operating Activities | -1 | 0 | -0 | -1 |
| Cash Flow from Investing Activities | 1 | 0 | -0 | -0 |
| Cash Flow from Financing Activities | 1 | -0 | -0 | 6 |
| Net Cash Inflow / Outflow | 0 | 0 | -0 | 5 |
| Closing Cash & Cash Equivalent | 0 | 1 | 0 | 5 |
| # | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|
| Earnings Per Share (Rs) | 0.37 | 0.26 | 4.5 | 3.43 |
| CEPS(Rs) | 0.54 | 0.43 | 4.61 | 3.81 |
| DPS(Rs) | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 3.37 | 3.63 | 7.78 | 24.17 |
| Core EBITDA Margin(%) | 4.53 | 1.56 | 9.79 | 8.62 |
| EBIT Margin(%) | 4.03 | 2.22 | 9.74 | 8.71 |
| Pre Tax Margin(%) | 2.77 | 1.21 | 9.11 | 8.01 |
| PAT Margin (%) | 1.27 | 0.9 | 7.09 | 6.12 |
| Cash Profit Margin (%) | 1.87 | 1.47 | 7.27 | 6.8 |
| ROA(%) | 3.05 | 2.21 | 30.73 | 17.89 |
| ROE(%) | 10.92 | 7.49 | 78.76 | 24.01 |
| ROCE(%) | 13.67 | 7.61 | 62.17 | 31.69 |
| Receivable days | 61.83 | 61.02 | 41.66 | 63.43 |
| Inventory Days | 0 | 0 | 0 | 0 |
| Payable days | 0 | 0 | 0 | 0 |
| PER(x) | 0 | 0 | 0 | 14.08 |
| Price/Book(x) | 0 | 0 | 0 | 2 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.14 | 0.1 | 0.05 | 0.68 |
| EV/Core EBITDA(x) | 3.04 | 3.43 | 0.51 | 7.23 |
| Net Sales Growth(%) | 0 | -0.23 | 118.46 | 55.13 |
| EBIT Growth(%) | 0 | -44.96 | 857.43 | 38.7 |
| PAT Growth(%) | 0 | -28.76 | 1611.35 | 33.99 |
| EPS Growth(%) | 0 | -28.76 | 1616.77 | -23.7 |
| Debt/Equity(x) | 1.54 | 1.31 | 0.48 | 0 |
| Current Ratio(x) | 1.31 | 1.36 | 1.61 | 5.39 |
| Quick Ratio(x) | 1.31 | 1.36 | 1.61 | 5.39 |
| Interest Cover(x) | 3.2 | 2.2 | 15.33 | 12.37 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 |
| # | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| Promoter | 59.36 | 59.36 | 59.36 | 59.36 | 59.36 |
| FII | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0.04 |
| Public | 40.64 | 40.64 | 40.64 | 40.64 | 40.6 |
| Others | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| Promoter | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 |
| FII | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 |
| Public | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
| Others | 0 | 0 | 0 | 0 | 0 |
| Total | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
You May Also Know About
